The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

BACKGROUND: The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk for developing medication overuse headache (MOH). Thus, new acutely acting antimigraine drugs are currently being developed, among which the small molecule CGRP...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hoogstraten, Willem Sebastiaan, MaassenVanDenBrink, Antoinette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734450/
https://www.ncbi.nlm.nih.gov/pubmed/31096904
http://dx.doi.org/10.1186/s10194-019-1007-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734450/
https://www.ncbi.nlm.nih.gov/pubmed/31096904
http://dx.doi.org/10.1186/s10194-019-1007-y

Ejemplares similares